Last edition
News about "topical phosphodiesterase 4 inhibitor"
Acrotech Biopharma Launches Adquey for Atopic Dermatitis in US
Acrotech Biopharma launches Adquey ointment in the US for the topical treatment of mild-to-moderate atopic dermatitis.
Topical Phosphodiesterase 4 Inhibitor | 01/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members